Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats

Olanzapine, an atypical antipsychotic, is efficient in stress associated psychiatric diseases, but its effect on the liver, a primary organ for drug activation and detoxification, still remains unclear. The effect of olanzapine administration (7.5mg/kg/day), on rat hepatic glutathione (GSH)-dependen...

Full description

Saved in:
Bibliographic Details
Main Authors: Todorović, Nevena (Author) , Gass, Peter (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: European journal of pharmaceutical sciences
Year: 2015, Volume: 81, Pages: 94-102
ISSN:1879-0720
DOI:10.1016/j.ejps.2015.10.010
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.ejps.2015.10.010
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0928098715300385
Get full text
Author Notes:Nevena Todorović, Nada Tomanović, Peter Gass, Dragana Filipović
Description
Summary:Olanzapine, an atypical antipsychotic, is efficient in stress associated psychiatric diseases, but its effect on the liver, a primary organ for drug activation and detoxification, still remains unclear. The effect of olanzapine administration (7.5mg/kg/day), on rat hepatic glutathione (GSH)-dependent defense and proinflammatory cytokines following 6weeks of chronic social isolation (CSIS), which causes depressive- and anxiety-like behavior in adult male Wistar rats, was investigated. The subcellular distribution of nuclear factor-κB (NF-κB), cytosolic inducible nitric oxide synthase (iNOS) protein levels and hepatic histological alterations were also determined. Decreased GSH content and glutathione reductase activity associated with increased catalase and glutathione S-transferase activity following CSIS indicated hepatic oxidative stress. Moreover, CSIS caused NF-κB nuclear translocation and the concomitant increase in iNOS together with increase in interleukin-1beta and tumor necrosis factor alpha protein levels, but no effect on interleukin-6. Olanzapine treatment suppressed NF-κB activation and iNOS expression and caused modulation of GSH-dependent defense systems but failed to reverse CSIS-induced increase in hepatic proinflammatory cytokines. Portal inflammation, focal hepatocyte necrosis and an increased number of Kupffer cells in CSIS rats (vehicle- or olanzapine-treated) were found. Olanzapine-treated socially reared rats showed portal inflammation and focal hepatocyte necrosis. Data suggest that CSIS compromised GSH-dependent defense, triggered a proinflammatory response and histological alterations in rat liver. Olanzapine treatment partially reversed the alterations in hepatic GSH-dependent defense, but showed no anti-inflammatory effect suggesting that it may provide protective effect against hepatic CSIS-induced oxidative stress, but not against inflammation.
Item Description:Gesehen am 22.01.2019
Available online 19 October 2015
Physical Description:Online Resource
ISSN:1879-0720
DOI:10.1016/j.ejps.2015.10.010